The use of URYX for reversible vasectomy in a rabbit model

Journal of Andrology

Volumn 25, Issue 4, 2004, Pages 545-553

  Naughton, Cathy K ^a   Myles, Jonathan ^b   Thomas Jr , Anthony J ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

DMSO; Epididymis; Testicle; Vas deferens

Indexed keywords

DIMETHYL SULFOXIDE; ETHYLENE VINYL ALCOHOL COPOLYMER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AZOOSPERMIA; BIOCOMPATIBILITY; CONTROLLED STUDY; EPIDIDYMIS; MALE; NONHUMAN; PRIORITY JOURNAL; SEMEN ANALYSIS; SPERMATOZOON COUNT; VAS DEFERENS; VASECTOMY;

EID: 3042777398     PISSN: 01963635     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1939-4640.2004.tb02825.x     Document Type: Article

References (24)

1. Abdala N, Levitin A, Dawson A, Maffra R Jr, Munoz-Ramirez H, Godec K, Dolmatch BL. Use of ethylene vinyl alcohol copolymer for tubal sterilization by selective catheterization in rabbits. J Vasc Interv Radiol. 2001;12:979-984.
2. Belker AM, Thomas AJ Jr, Fuchs EF, Konnak JW, Sharlip ID. Results of 1,469 microsurgical vasectomy reversals by the Vasovasostomy Study Group. J Urol. 1991;145:505-511.
3. Brueschke EE, Burns M, Maness JH, Wingfield JR, Mayerhofer K, Zaneveld LJ. Development of a reversible vas deferens occlusive device. I. Anatomical size of the human and dog vas deferens. Fertil Steril. 1974a;25:659-672.
4. Brueschke EE, Kaleckas RA, Wingfield JR, Welsh TJ, Zaneveld LJ. Development of a reversible vas deferens occlusion device. VII. Physical and microscopic observations after long-term implantation of flexible prosthetic devices. Fertil Steril. 1980;33:167-78.
5. Brueschke EE, Wingfield JR, Burns M, Zaneveld JD. Development of a reversible vas deferens occlusive device. II. Effect of bilateral and unilateral vasectomy on semen characteristics in the dog. Fertil Steril. 1974b;25:673-686.
6. Brueschke EE, Zaneveld LJ, Kaleckas RA, Wingfield JR. Development of a reversible vas deferens occlusive device. VI. Long-term evaluation of flexible prosthetic devices. Fertil Steril. 1979;31:575-86.
7. Brueschke EE, Zaneveld LJ, Rodzen R, Berns D. Development of a reversible vas deferens occlusive device. 3. Morphology of the human and dog vas deferens: a study with the scanning electron microscope. Fertil Steril. 1974c;25:687-702.
8. Brueschke EE, Zaneveld LJ, Rodzen R, Mayerhoffer K, Burns M, Wingfield JR. Development of reversible vas deferens occlusive device. V. Flexible prosthetic devices. Fertil Steril. 1975;26:40-52.
9. Carroll JC, Schwaitzberg SD, Ucci AA Jr, Schlesinger RM, Lauritzen D, Sant GR. New matrix material for potential use in "reversible" vasectomy: preliminary animal biocompatibility studies. Urology 1993; 41:34-37.
10. Chaloupka JC, Huddle DC, Alderman J, Fink S, Hammond R, Vinters HV. A reexamination of the angiotoxicity of superselective injection of DMSO in the swine rete embolization model. AJNR Am J Neuroradiol. 1999;20:401-410.
11. Chen Z, Gu Y, Liang X, Shen L, Zou W. Morphological observations of vas deferens occlusion by the percutaneous injection of medical polyurethane. Contraception 1996;53:275-279.
12. Engelmann UH, Schramek P, Tomamichel G, Deindl F, Senge T. Vasectomy reversal in central Europe: results of questionnaire of urologists in Austria, Germany and Switzerland. J Urol. 1990;143:64-67.
13. Fuchs EF, Burt RA. Vasectomy reversal performed 15 years or more after vasectomy: correlation of pregnancy outcome with partner age and with pregnancy results of in vitro fertilization with intracytoplasmic sperm injection. Fertil Steril. 2002;77:516-519.
14. Lohiya NK, Manivannan B, Mishra PK. Repeated vas occlusion and non-invasive reversal with styrene maleic anhydride for male contraception in langur monkeys. Int J Androl. 2000;23:36-42.
15. Marquette CM, Koonin LM, Antarsh L, Gargiullo PM, Smith JC. Vasectomy in the United States, 1991. Am J Public Health 1995;85:644-649.
16. Murayama Y, Vinuela F, Ulhoa A, Akiba Y, Duckwiler GR, Gobin YP, Vinters HV, Greff RJ. Nonadhesive liquid embolic agent for cerebral arteriovenous malformations: preliminary histopathological studies in swine rete mirabile. Neurosurgery 1998;43:1164-1175.
17. Nahser HC, Kühne D, Feiden W. Preliminary report on the use of Onyx liquid embolic system for the treatment of brain arteriovenous malformations. Irvine, Calif: Micro Therapeutics Inc; 1999.
18. Naughton CK, Nelson DR, Thomas AJ Jr. Development of an inexpensive artificial vagina for semen collection from rabbits. J Androl. 2003;24: 712-715.
19. Philp T, Guillebaud J, Budd D. Complications of vasectomy: review of 16,000 patients. Br J Urol. 1984;56:745-748.
20. Sharlip ID. What is the best pregnancy rate that may be expected from vasectomy reversal? J Urol. 1993;149:1469-1471.
21. Silber SJ. Pregnancy after vasovasostomy for vasectomy reversal: a study of factors affecting long-term return of fertility in 282 patients followed for 10 years. Hum Reprod. 1989;4:318-322.
22. Soebadi DM, Gardjito W, Mensink HJ. Intravasal injection of formed-in-place medical grade silicone rubber for vas occlusion. Int J Androl. 1995;18(suppl 1):45-52.
23. Trussel J, Levesque JA, Koenig JD, et al. The economic value of contraception: a comparison of 15 methods. Am J Public Health 1995;85: 494-503.
24. Wright KC, Greff RJ, Price RE. Experimental evaluation of cellulose acetate NF and ethylene-vinyl alcohol copolymer for selective arterial embolization. J Vasc Interv Radiol. 1999;10:1207-1218.